What does the term "targeted therapy" refer to in the context of biotherapy?

What does the term "targeted therapy" refer to in the context of biotherapy?

• A. Non-specific treatments for cancer
• B. Therapies that focus on specific molecular targets associated with cancer
• C. Broad-spectrum medications that affect all cells
• D. Therapies designed for only one type of cancer

Answer: (B)

The term "targeted therapy" in the context of biotherapy specifically refers to therapies that focus on particular molecular targets that are associated with cancer. This approach is based on the understanding that cancer cells often have specific genetic mutations or dysregulated pathways that differentiate them from normal cells. Targeted therapies are designed to interfere with these unique processes, aiming to inhibit cancer cell growth and survival without affecting healthy cells as broadly as conventional chemotherapies can. This method is more precise and personalized compared to traditional treatments. By identifying and attacking specific targets, these therapies can enhance treatment efficacy and reduce side effects, offering a more tailored approach to cancer treatment. In contrast, non-specific treatments or broad-spectrum medications do not focus on particular molecular characteristics, making them less effective at selectively targeting cancer cells. Additionally, restricting therapies to just one type of cancer without consideration for the broader molecular targets available may limit their applicability and effectiveness across different cancers that share similar pathways. Thus, targeted therapy’s focus on specific molecular targets is what distinguishes it and makes it particularly valuable in cancer biotherapy.

The term "targeted therapy" in the context of biotherapy specifically refers to therapies that focus on particular molecular targets that are associated with cancer. This approach is based on the understanding that cancer cells often have specific genetic mutations or dysregulated pathways that differentiate them from normal cells. Targeted therapies are designed to interfere with these unique processes, aiming to inhibit cancer cell growth and survival without affecting healthy cells as broadly as conventional chemotherapies can.

This method is more precise and personalized compared to traditional treatments. By identifying and attacking specific targets, these therapies can enhance treatment efficacy and reduce side effects, offering a more tailored approach to cancer treatment.

In contrast, non-specific treatments or broad-spectrum medications do not focus on particular molecular characteristics, making them less effective at selectively targeting cancer cells. Additionally, restricting therapies to just one type of cancer without consideration for the broader molecular targets available may limit their applicability and effectiveness across different cancers that share similar pathways. Thus, targeted therapy’s focus on specific molecular targets is what distinguishes it and makes it particularly valuable in cancer biotherapy.